July/August #156 : Hand to Mouth - by David Evans

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

Child, Alive

In the Eye of the Beholder




Troubled Minds

Be a Brainiac

Family Planning

The Heart of the Matter

Med Alert

Hep C

Hairdo

Kombucha Tea to...Gila Monster Spit?

Cool Veggies, Hot Flavors

Hand to Mouth

Bar Resistance




Provide and Conquer

Good Habits

Summer Musts!

Breaking Barriers

EXTRA! EXTRA!

Maybe Baby




Editor's Letter-July/August 2009

Your Feedback-July/August 2009

No Child Left Behind



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

July / August 2009


Hand to Mouth

by David Evans

The drug companies offer financial savings to those who struggle to pay for their antiretrovirals.

Thanks to government-funded AIDS drug assistance programs (ADAPs) and other public benefits, 75 percent of people living with HIV in the United States receive their antiretrovirals (ARVs) for little or no cost. But others, who are either underinsured or uninsured or who make too much money to qualify for federal assistance, must pay out of their pockets for their meds. The expense can cause serious financial strain, making it difficult to afford everyday necessities and hindering some from continuing their ARV regimens. To help, pharmaceutical companies have created patient assistance programs (PAPs) and co-payment programs.

Each company that makes an ARV offers a PAP that provides free HIV meds and even other types of medicines as well, but to qualify, you must prove that you have exhausted all other options and cannot afford private health insurance. Lei Chou, a longtime AIDS activist who currently works for Treatment Action Group in New York City, warns that this process can be tedious. “It’s not going to be a situation of you making one phone call and the company says, ‘Okay!’” Chou says.

Co-payment programs don’t provide free meds, but they pay a portion of the costs for those who have steep monthly co-pays. So far, only GlaxoSmithKline (GSK), Abbott, Gilead, Tibotec and Bristol-Myers Squibb (BMS) offer this type of program, and not all drugs are covered—notably Norvir in low doses, which is used as a booster for many protease inhibitors. *

If you need a PAP or a co-payment program, talk to your doctor or health care provider. Also ask about a patient savings card, a rebate program offered by some companies.

Especially in these dire times, Wall Street fat cats aren’t the only ones who should get a bailout.     

TIP: To learn more about theses types of programs, read David Evans’s Web Exclusive, “Best Kept Secret: Drug Company Assistance Programs.” It provides an honest, up-to-date look at these initiatives and includes an extensive chart that breaks down each program and lists contact information for each pharmaceutical company.

* Correction: The asterisked sentence above has been updated from the original version, which did not list GlaxoSmithKline (GSK) as one of the companies that provide a co-payment program. GSK offers a Patient Savings Card that covers up to $100 per month for GSK product co-pays, beginning with the first co-pay dollar amount. Visit mysupportcard.com for more information.

Check out the upcoming POZ Focus on Money Management for more information on patient assistant programs (PAPs) and co-payment programs.

Search: prison, meds, hiv,


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    aqua_31206
    Macon
    Georgia


    Loveladyd
    Washington
    DC


    Fred9774
    Brooklyn
    New York

This could be you!
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Will decriminalizing injection drug use help end the global HIV epidemic?
Yes
No

Survey
PrEP Course

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.